NOTICE – The Fonds de recherche du Québec (FRQ) was established on June 1, 2024, in accordance with the Act to amend the Act respecting the Ministère de l’Économie et de l’Innovation with respect to research. The Fonds de recherche du Québec – Nature et technologies (FRQNT), the Fonds de recherche du Québec – Santé (FRQS) and the Fonds de recherche du Québec – Société et culture (FRQSC) have since been regrouped into the new FRQ, which continues their existence. The rights and obligations of the FRQNT, FRQS and FRQSC have become those of the FRQ; activities continue as usual.

Please note that if you come across an old name or logo of one of the Fonds de recherche du Québec in the program rules or on the website, it should now read as follows:

  • The FRQNT becomes the Nature et technologies sector;
  • The FRQS becomes the Santé sector;
  • The FRQSC becomes the Société et culture sector.

Thank you for your understanding.

Diane

CEO

Diane Côté is the CEO of the MEDTEQ industrial research consortium, whose objective it is to accelerate the development of innovative medical technologies by supporting collaborative projects developed by teams of industrial and academic partners in Québec. She is a member of the Board of Directors of the Fonds de recherche du Québec – Santé. She is Board Chair and Chair of the Executive Committee of the MedDev Commercialization Centre (MDCC), a Canadian centre of excellence for commercialization and research (CECR) in the medical technology sector. She is a member of the Board of Directors of CIMTEC, a CECR for the commercialisation of Imaging Technology. She is also a member of the Life Sciences Practice Advisory Board of Foreign Affairs, Trade and Development Canada.

She previously served as Vice-president, Québec of MEDEC, the national association created by and for the Canadian medical technology industry. During her work in industry, she was CEO of a medical technology company specialising in state-of-the-art mathematical modeling and neural networks for risk management in obstetrics. She worked at IBM as a member of the Sales and Communications management team. She also lead numerous mandates in strategic planning, financing and partnerships at Innovitech, a consulting company focusing on new technologies and on the development of innovative economic models.